Forbes contributors publish independent expert analyses and insights. I write about the business of healthcare. Sep 09, 2020, 07:00am EDT This article is more than 5 years old. Chris Gibson, ...

Bayer Aktiengesellschaft BAYRY entered into a strategic collaboration agreement with Recursion Pharmaceuticals, Inc., a digital biology company industrializing drug discovery for the treatment of ...

Recursion said today it is eliminating approximately 20% of its workforce—about 160 jobs—in a restructuring the AI-based drug developer said reflects both its recently-pruned pipeline and the ...

Recursion Inc.’s combination of machine learning and artificial intelligence, coupled to its wet lab work, caught Bayer AG’s attention so solidly that its investment unit, Leaps by Bayer, led the ...

For three weeks last May, employees of the AI giant Nvidia and Recursion Pharmaceuticals slept on the floor of a data center in Salt Lake City. They were there to build a machine that Recursion, a ...

Recursion—the computational capacity to embed elements within elements of the same kind—has been lauded as the intellectual cornerstone of language, tool use and mathematics. A multi-institutional ...

(RTTNews) - Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) and U.S.-based Recursion Pharmaceuticals, Inc., said Wednesday that have entered into a strategic collaboration agreement. The partnership will ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...